Medicare added Novo Nordisk's Ozempic, Wegovy, and Rybelsus to its 2027 drug price negotiations list. This move could force Novo Nordisk to slash the costs of its top drugs. The company should ...

In the shadow of President Trump's efforts to lower drug prices, the Medicare drug price negotiation process that began in ...

Novo Nordisk anticipates that the next round of ... that they’re “ready for that,” Bloomberg reported. Through the Medicare Drug Price Negotiation Program, the U.S. government aims to ...

That question is at the heart of an unusual challenge that the pharma company Novo Nordisk is pursuing against ... have major ramifications for the Medicare drug price negotiation program, a ...

PITTSBURGH (CN) — Bashing a Biden-era law that gives Medicare the power to directly negotiate the price of certain high-cost prescription drugs, an attorney for the pharmaceutical giant Novo Nordisk ...

That question is at the heart of an unusual challenge that the pharma company Novo Nordisk is pursuing against ... have major ramifications for the Medicare drug price negotiation program, a ...

Novo Nordisk had a head start ... and some have refused to cover them. In most cases, Medicare will not pay for the drugs to treat obesity. The Trump administration recently rejected a Biden ...

Novo Nordisk said on Thursday it plans to start late-stage trials of amycretin injection and oral drugs during the first ...

However, the Centers for Medicare and Medicaid Services (CMS) could soon throw a monkey wrench into Novo Nordisk's momentum. The agency announced last week that Ozempic and Wegovy, along with Novo ...